This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Why PetMed (PETS) is a Top Momentum Stock for the Long-Term
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Fiverr International (FVRR) Matches Q1 Earnings Estimates
by Zacks Equity Research
Fiverr (FVRR) delivered earnings and revenue surprises of 0% and 1.17%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
1stdibs.com (DIBS) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
1stdibs (DIBS) delivered earnings and revenue surprises of 11.11% and 3.58%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
MercadoLibre (MELI) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
MercadoLibre (MELI) delivered earnings and revenue surprises of 2.11% and 9.86%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
PetMed (PETS) Reports Break-Even Earnings for Q2
by Zacks Equity Research
PetMed (PETS) delivered earnings and revenue surprises of -100% and 7.95%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
PetMeds (PETS) to Advance Pet Care With New Collaboration
by Zacks Equity Research
PetMeds (PETS) is positioning itself more firmly in the field of pet health and wellness as a result of its established reputation in the pet pharmaceutical industry.
PetMed (PETS) Reports Break-Even Earnings for Q1
by Zacks Equity Research
PetMed (PETS) delivered earnings and revenue surprises of -100% and 1.26%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Implied Volatility Surging for PetMed Express (PETS) Stock Options
by Zacks Equity Research
Investors need to pay close attention to PetMed Express (PETS) stock based on the movements in the options market lately.
Time for Pet ETF on Upbeat Earnings from Chewy? (Revised)
by Sanghamitra Saha
The recent impressive earnings report from Chewy, the online pet-products retailer, may ignite investor optimism in the segment and its pure-play ETF PETS.
PetMed (PETS) Misses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
PetMed (PETS) delivered earnings and revenue surprises of -73.33% and 10.76%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Fiverr International (FVRR) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Fiverr (FVRR) delivered earnings and revenue surprises of 50% and 0.49%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
1stdibs.com (DIBS) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
1stdibs (DIBS) delivered earnings and revenue surprises of 12.50% and 2.68%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
BigCommerce (BIGC) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
BigCommerce (BIGC) delivered earnings and revenue surprises of 46.15% and 0.30%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
PetMed (PETS) Lags Q3 Earnings and Revenue Estimates
by Zacks Equity Research
PetMed (PETS) delivered earnings and revenue surprises of -90.48% and 7.59%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Amazon (AMZN) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Amazon (AMZN) delivered earnings and revenue surprises of 40% and 2.64%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
ETFs & Stocks to Win Despite a Soft December Retail Sales
by Sanghamitra Saha
Retail sales in the United States fell 1.1% sequentially in December 2022. Year-over-year, retail sales grew 9.2%.
PetMed (PETS) Misses Q2 Earnings Estimates
by Zacks Equity Research
PetMed (PETS) delivered earnings and revenue surprises of -51.85% and 0.61%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
November Retail Sales Steady: 3 ETF & Stock Picks
by Sanghamitra Saha
3 ETF and stocks to play the surge in retail sales in November.
Earnings Preview: Amazon (AMZN) Q3 Earnings Expected to Decline
by Zacks Equity Research
Amazon (AMZN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Pet Industry Seems Recession-Proof: ETF & Stocks in Focus
by Sanghamitra Saha
American Pet Products Association, 70% of U.S. households own a pet, as quoted on Yahoo Finance. And Americans are splurging on their pets despite high inflation.
Analysts Estimate PetMed (PETS) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
PetMed (PETS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Invest Like Value Stock Gurus
by Tracey Ryniec
What are the Buffett and Graham-like stocks in 2022?
PetMed (PETS) Q1 Earnings and Revenues Lag Estimates
by Zacks Equity Research
PetMed (PETS) delivered earnings and revenue surprises of -46.15% and 13.03%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
PetMed (PETS) Q4 Earnings Top Estimates
by Zacks Equity Research
PetMed (PETS) delivered earnings and revenue surprises of 11.11% and 2.65%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Cars.com (CARS) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Cars.com (CARS) delivered earnings and revenue surprises of 100% and 0.64%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?